StriatechJournal Club
Inherited Retinal Dystrophy: Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration
T.J. Hollingsworth, PhD - University of Tennessee Health Science Center
Live date: Wed, 05 Apr 2023
Time:
07:00 a.m. (US, West coast)
10:00 a.m. (US, East coast)
14:00 (UTC)
16:00 (Germany)
22:00 (Beijing, Perth)
23:00 (Seoul, Tokyo)
24:00 (Sydney)
Register Now
Instructions for watching
Description
The BXD32 mouse is a model of polygenic inheritance retinal dystrophy (IRD). IRD is a set of congenital heterogenous blinding diseases caused by the death of rod and cone photoreceptors of the retina. Patients with IRDs can begin losing sight as early as childhood and can be completely blind by adolescence. They may also begin losing sight as an adult and blind in older age. The age of onset and rate of degeneration varies with the gene that is mutated and other genetic and environmental factors. A commonality amongst these diseases is the presence of overactive inflammatory cells and pathways. In this study, using various methods including optomotor behavioral measurements with Striatech’s OptoDrum, electroretinography, optical coherence tomography, funduscopy, and immunohistochemistry, we have shown that this chronically elevated proinflammatory environment is not only a byproduct of the degenerative disease, but an actual driver of the disease itself.
Key Topics
- IRD signs, symptoms, and endophenotypes
- The genes that underly the IRD diseases
- Current treatments and possible future treatments and cures
Learning Objectives
Scienctists should be able to understand the hallmarks of IRDs including signs and symptoms of IRDs as well as the endophenotypes of IRDs. They should also learn the genetic factors underlying IRDs and how these interplay with the retina and other organ systems. They will also learn about possible treatments for IRDs and where the scientific and medical communities are in the treatment of and cures for IRDs.
Background Reading
Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration in a Spontaneous Polygenic Model of Inherited Retinal Dystrophy. Hollingsworth TJ, Wang X, White WA, Simpson RN, Jablonski MM.
Front Pharmacol. 2022 Mar 21;13:839424.
doi: 10.3389/fphar.2022.839424.
The Severe Autosomal Dominant Retinitis Pigmentosa Rhodopsin Mutant Ter349Glu Mislocalizes and Induces Rapid Rod Cell Death. Hollingsworth, T. J., and Gross, A. K. (2013).
J. Biol. Chem. 288 (40), 29047–29055.
doi: 10.1074/jbc.M113.495184
Proinflammatory Pathways Are Activated in the Human Q344X Rhodopsin Knock-In Mouse Model of Retinitis Pigmentosa. Hollingsworth, T. J., Hubbard, M. G., Levi, H. J., White, W., Wang, X., Simpson, R., et al. (2021).
Biomolecules 11 (8), 1163.
doi: 10.3390/biom11081163
Using BXD Mouse Strains in Vision Research: A Systems Genetics Approach. Geisert, E. E., and Williams, R. W. (2020).
Mol. Vis. 26, 173–187.
PMID: 32180682
A Platform for Experimental Precision Medicine: The Extended BXD Mouse Family. Ashbrook, D. G., Arends, D., Prins, P., Mulligan, M. K., Roy, S., Williams, E. G., et al. (2021).
Cell Syst 12 (3), 235.
doi: 10.1016/j.cels.2020.12.002
Reviews:
Defective Trafficking of Rhodopsin and its Role in Retinal Degenerations. Hollingsworth, T. J., and Gross, A. K. (2012).
Int. Rev. Cel Mol Biol 293, 1–44.
doi: 10.1016/B978-0-12-394304-0.00006-3
Inflammation in the Pathogenesis of Progressive Retinal Dystrophies. Jordan, K. E., Jablonski, M. M., and Hollingsworth, T. J. (2021).
J. Ophthalmic Res. Vis. Care 1 (1).
doi: 10.54289/JORVC2100103
About the speaker
T.J. Hollingsworth, PhD
Assistant Professor
University of Tennessee Health Science Center
T.J. received his PhD from the Vision Science Graduate Program at the University of Alabama at Birmingham in 2013 and completed two postdocs at the University of Oklahoma Health Science Center and at the University of Tennessee Health Science Center (UTHSC) by 2015. From 2015 to 2019, T.J. was the technical director of the Neuroscience Institute Imaging Facility and became a faculty member in the Department of Ophthalmology at UTHSC in 2019. Since then, T.J. has been working with his faculty mentor, Dr Monica M. Jablonski, to study age-related macular degeneration, glaucoma and inherited retinal dystrophies.
Register now
Journal Club: Inherited Retinal Dystrophy: Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration
Apr 05th, 2023
Apr 05th, 2023
Other Journal Clubs and Webinars
Q&A available
Wednesday, 25 Jan 2023
Journal Club: Developing Retinal Gene Therapy for Zellweger Spectrum Disorder (ZSD)
Catherine Argyriou, PhD - McGill University, Dept of Human Genetics
Peroxisomal disorders and the PEX1-G844D mouse model for mild Zellweger Spectrum Disorder (ZSD), leads to retinal degeneration and vision loss. Catherine Argyriou will describe how her team used AAV8-mediated gene delivery to robustly and durably improve functional vision, retinal response, retinal structure, and biochemical metabolites in ZSD-mice.
- Related Products:
- OptoDrum
Q&A available
Wednesday, 09 Nov 2022
Journal Club: In Vivo Modeling of Immune-mediated Optic Neuropathies
Oliver W. Gramlich, Ph.D. - The University of Iowa
This presentation will outline the pathobiology and visual phenotype of immune mediated optic neuropathies that include Multiple Sclerosis (MS), Neuromylitis optica spectrum disorders (NMOSD), and Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
- Related Products:
- OptoDrum
Q&A available
Wednesday, 20 Jul 2022
Journal Club: Endothelial Caspase-9 Mediates Inflammatory and Vision Function Changes in Retinal Vascular Injury
Crystal Colón Ortiz, Ph.D. - Columbia University Medical Center
In retinal vein occlusion (RVO), non-apoptotic expression of endothelial caspase-9 (EC Casp9) induces pathology including retinal edema, capillary ischemia, and neurodegeneration. Crystal Colón Ortiz presents mechanistic insights into EC Casp9 action, and the behavioral consequences such as contrast sensitivity decline.
- Related Products:
- OptoDrum
- Applications:
Q&A available
Tuesday, 22 Mar 2022
Journal Club: Anti-FcRn Treatment in Antibody-Associated Experimental Autoimmune Encephalomyelitis
Jana Remlinger, MSc - Department of Neurology, Inselspital, Bern University Hospital and Department for BioMedical Research (DBMR)
Jana Remlinger et al. showed preserved visual function and ameliorated course of disease after anti-FcRn treatment in an experimental model using a monoclonal MOG-IgG to mimic MOGAD.
- Related Products:
- OptoDrum
Wednesday, 17 Nov 2021
Webinar: AcuiSee – Rodent Visual Acuity Using Behavioral Conditioning
Dr. Jeffrey A Jamison - Experimentica Ltd.
In this Webinar, Dr. Jeff Jamison will talk about “AcuiSee”, with which one can measure rodent vision based on an operant conditioning paradigm. Jeff is the developer of AcuiSee, and he now works as Director of In-Vivo Pharmacology at Experimentica.
- Related Products:
- AcuiSee
Q&A available
Thursday, 07 Oct 2021
Journal Club: IR Photorefraction and IR Photokeratometry – Measuring Refractive State and Corneal Curvature in Animals and Humans
Prof. Frank Schaeffel - University of Tübingen, Germany
It is difficult to measure small eyes of animal models. In this Journal Club, Prof. Frank Schaeffel presents his inventions for IR photorefraction and IR photokeratometry that facilitate such measurements. He focuses on the history, application, advantages, optics, software algorithms and calibration.
- Applications:
- Myopia
Q&A available
Thursday, 22 Jul 2021
Journal Club: Echolocation with Light – A New Form of Active Sensing in Fish?
Prof. Nico K. Michiels - University of Tübingen, Germany
Some fish use active photolocation: Their eyes emit light to detect predators or pray in this spotlight. In this Journal Club, Prof. Nico Michiels from the University of Tübingen will talk about his fascinating journey in which he has discovered this phenomenon.
- Related Products:
- OptoDrum
- Applications:
- Vision Science
Q&A available
Thursday, 27 May 2021
Journal Club: Assessing Neuroinflammation-related Neural Damage by Monitoring the Retinotectal System
PD Dr. Janos Groh - Department of Neurology, Section of Developmental Neurobiology, University Hospital Würzburg
Neuroinflammation amplifies neural damage caused by genetic disorders or aging. Groh et al show that neuroinflammation has deleterious consequences for the optic nerve, and disease progression can be monitored with the OptoDrum.
- Related Products:
- OptoDrum
Q&A available
Thursday, 25 Mar 2021
Journal Club: Restoring vision – Optogenetic gene therapy targeted at human ON-bipolar cells
Dr. Elmar Hulliger - Institute of Physiology, University of Bern
Optogenetic gene therapy holds great promise for healing blindness. Hulliger et al have developed a new promoter that effectively targets human ON bipolar cells. This is an important step towards clinical applications of optogenetic gene therapy for restoring vision.
- Related Products:
- OptoDrum
Q&A available
Thursday, 28 Jan 2021
Journal Club: The role of Nogo-A in visual deficits induced by retinal injury.
Julius Baya Mdzomba, PhD - Université Laval
Nogo-A, an inhibitor of neural growth, prevents regeneration after injury. Blocking of Nogo-A aides recovery, also in the visual system after retinal damage. Baya Mdzomba show with our OptoDrum that visual behavior benefits from Nogo-A neutralization after retinal damage typically found in diabetic retinopathy or glaucoma.
- Related Products:
- OptoDrum
Thursday, 08 Oct 2020
Webinar: Visual Acuity as a Relevant Phenotype in Mouse Models of Rare Disease
Zoë Bichler, PhD - The Jackson Laboratory
Maximiliano Presa, PhD - The Jackson Laboratory
The Jackson Laboratory will introduce their Neurobehavior Phenotyping Core, in which they also do visual acuity measurements. They will present two examples where the OptoDrum has been used to characterizte vision in animal models for rare disease: The Charcot-Marie-Tooth-disease, and Multiple-Sulfatase-Deficiency.
- Related Products:
- OptoDrum
